7th International Conference on Tularemia 2012

描述(申请人提供)：图拉热症是一种严重的致命疾病，流行于整个北半球。它是由已知的最具传染性的病原体之一--图拉方济氏菌引起的。图拉氏丝孢杆菌已被列为CDC和NIAID A类优先病原体，在生物防御方面具有最高的重要性。在过去的十年里，世界各地积极从事图拉氏丝虫研究的科学家人数大幅增加。尽管大量研究都在积极关注图拉氏丝虫病，但全世界科学家聚集在一起的唯一会议是关于图拉热症的国际会议，该会议每三年举行一次。该项目的具体目的是确保获得资金，以帮助与会者参加将于2012年秋季在科罗拉多州举行的第七届图拉热病国际会议。具体地说，需要资金支付所有参与者(估计275人)的部分注册费用，并进一步支付注册费。 为受训人员(估计50名研究生)提供差旅，并为6-8名研究人员提供旅费，否则他们将无法参加会议。2012年第七届图拉热病国际会议的总体目标是聚集来自学术、公共卫生、私营和国防机构的250-300名科学家以及临床医生、博士后研究员和研究生，介绍基因组和蛋白质组学、发病机制、动物模型和毒力因素、人类感染和诊断、流行病学、生态学和人口遗传学/分类学、宿主反应、免疫学和细胞生物学以及治疗学和疫苗等关键主题领域的最新研究成果。最终，科学家们有机会在这次会议上会面并讨论他们个人的研究成果，应该有助于激发新的想法，促进新的合作，并导致更快地发展改进的图拉氏菌诊断、治疗和疫苗。 与公共卫生相关：图拉热症是一种威胁生命的疾病，在整个北半球都有发生；它具有生物防御和公共卫生意义，世界各地的许多实验室都在研究引起图拉氏菌的病原体。为了出席将于2012年9月17日至20日在科罗拉多州举行的第七届图拉热病国际会议，正在申请资金，以支付所有与会者(特别是学生)的注册费，以及需要特别援助才能参加会议的与会者的旅费。这次会议将为科学家提供会面和分享信息的机会，促进新的合作，并最终为图拉热症的新诊断、治疗和疫苗的开发做出贡献。

DESCRIPTION (provided by applicant): Tularemia is a severe and fatal disease endemic throughout the Northern Hemisphere. It is caused by the bacterium Francisella tularensis, one of the most infectious pathogens known. F. tularensis has been classified as a CDC and NIAID Category A priority pathogen, of highest importance with respect to biodefense. In the last decade there has been a large increase in the number scientists worldwide actively engaged in F. tularensis research. Despite the amount of research actively focused on F. tularensis, the only meeting to bring together scientists worldwide is the International Conference on Tularemia, which only occurs every three years. The specific aim of this project is to secure funding to aid participant attendance at the 7th International Conference on Tularemia to be held in Colorado in the Fall of 2012. Specifically, funds are requested to defray a portion of registration costs for all participants (estimated 275 attendees), further defray registration fees for trainees (estimated 50 graduate students) and provide travel for 6-8 researchers who would not otherwise be able to attend the conference. The overall objective of the 7th International Conference on Tularemia 2012 is to bring together 250-300 scientists from academic, public health, private and defense institutions as well as clinicians, postdoctoral fellows and graduate students to present the latest findings in the key theme areas of genomics and proteomics, pathogenesis, animal model and virulence factors, human infection and diagnosis, epidemiology, ecology and populations genetics/taxonomy, host response, immunology and cell biology, and therapeutics and vaccines. Ultimately, the opportunity for scientists to meet and discuss their individual research findings at this conference should serve to spark new ideas, foster new collaborations, and lead to more rapid development of improved diagnostics, therapeutics and vaccines for F. tularensis. PUBLIC HEALTH RELEVANCE: Tularemia is a life-threatening disease which occurs throughout the Northern Hemisphere; it is of biodefense and public health significance with many laboratories worldwide studying the causative pathogen, Francisella tularensis. To enable attendance at the 7th International Conference on Tularemia to be held in Colorado September 17-20, 2012, funds are being requested to defray costs of registration fees for all participants (particularly students) as well as travel costs for attendees requiring special assistance to atten the meeting. This conference will provide the opportunity for scientists to meet and share information, foster new collaborations, and ultimately contribute to the development of new diagnostics, therapeutics and vaccines for tularemia.